[1] 马梁,王保福,王显.房颤的治疗与管理研究进展[J].浙江医学,2024,46(9):1003-1008. [2] Reddy V Y,Doshi S K,Kar S,et al.5-year outcomes after left atrial appendage closure:from the PREVAIL and PROTECT AF trials[J].J Am Coll Cardiol,2017,70(24):2964-2975. [3] 王群山,陈牧,孙健,等.心房颤动导管消融联合左心耳封堵一站式手术的可行性和围术期安全性分析[J].中华心血管病杂志,2020,48(10):842-847. [4] Swaans MJ, Post MC, Rensing BJ, et al.Ablation for atrialfibrillation in combination with left atrial appendageclosure: first results of a feasibility study[J]. J Am HeartAssoc, 2012, 1(5): e002212. [5] Phillips KP, Pokushalov E, Romanov A, et al.Combining Watchman left atrial appendage closure and catheterablation for atrial fibrillation: multicentre registry resultsof feasibility and safety during implant and 30 daysfollowup[J]. Europace, 2018, 20(6): 949-955. [6] Hindricks G,Potpara T,Dagres N,et al.2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC[J].Eur Heart J,2021,42(5):373-498. [7] Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J].Europace,2018,20(1):e1-e160. [8] Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962. [9] Kirchhof P, Benussi S, Kotecha D, et al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace,2016, 18(11): 1609-1678. [10] Boersma LV, Ince H, Kische S, et al.Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the Watchman left atrial appendage closure technology: final 2-year outcome data of the ewolution trial focusing on history of stroke and hemorrhage[J]. Circ Arrhythm Electrophysiol, 2019, 12(4): e006841. [11] Reddy VY, Doshi SK, Kar S, et al. 5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials[J]. J Am Coll Cardiol, 2017, 70(24):2964-2975. [12] Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg.2018 Jun 1;53(6):1112-1117. [13] 黄福强,杜春霖,孙梦辉,宁冰,罗颖,安胜利.倾向评分配比在SPSS软件上的实现[J].南方医科大学学报,2015,35(11):1597-1601. [14] 尹月娇,孙守刚.导管消融联合左心耳封堵一站式手术治疗非瓣膜性房颤的临床应用进展[J].山东医药,2022,62(34):92-95. [15] 张澎湃,李毅刚.心房颤动导管消融联合左心耳封堵一站式手术策略研究与应用进展[J].中华心血管病杂志,2023,51(9):922-929. |